References
- Wu X, Chen C, Luo B, et al. Nuclear ING3 expression is correlated with a good prognosis of breast cancer. Front Oncol. 2020;10:589009.
- Gargiulo L, Rivero EM, Di Siervi N, et al. Agonist effects of propranolol on non-tumor human breast cells. Cells. 2020. 9(4):1036.
- Houghton LC, Howland RE, McDonald JA. Mobilizing breast cancer prevention research through smartphone apps: a systematic review of the literature. Front Public Health. 2019;7:298.
- Du L, Li X, Zhen L, et al. Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway. Mol Med Rep. 2018;17:7163–7169.
- Wang Z, Li TE, Chen M, et al. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway. Aging (Albany NY). 2020;12:1867–1887.
- Xie X, Xiao Y, Huang X. Homeobox C10 knockdown suppresses cell proliferation and promotes cell apoptosis in osteosarcoma cells through regulating caspase 3. Onco Targets Ther. 2018;11:473–482.
- Adato O, Orenstein Y, Kopolovic J, et al. Quantitative analysis of differential expression of HOX genes in multiple cancers. Cancers (Basel). 2020;12(6):1572.
- Dai BW, Yang ZM, Deng P, et al. HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma. J Cancer. 2019;10:4540–4551.
- Ma K, Zhao C, Guo K, et al. Low HOXC10 expression in liver cancer regulates proliferation via a mechanism involving miR-221 and the MAPK signaling pathway. Oncol Lett. 2020;20:127.
- Peng Y, Li Y, Li Y, et al. HOXC10 promotes tumour metastasis by regulating the EMT-related gene Slug in ovarian cancer. Aging (Albany NY). 2020;12:19375–19398.
- Yao S, He L, Zhang Y, et al. HOXC10 promotes gastric cancer cell invasion and migration via regulation of the NF-κB pathway. Biochem Biophys Res Commun. 2018;501:628–635.
- Ansari KI, Hussain I, Kasiri S, et al. HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4. J Mol Endocrinol. 2012;48:61–75.
- Zhang Q, Wang Z, Cheng X, et al. lncRNA DANCR promotes the migration an invasion and of trophoblast cells through microRNA-214-5p in preeclampsia. Bioengineered. 2021;12(2):9424-9434.
- Zhou X, Wang Z, Xu B, et al. Long non-coding RNA NORAD protects against cerebral ischemia/reperfusion injury induced brain damage, cell apoptosis, oxidative stress and inflammation by regulating miR-30a-5p/YWHAG. Bioengineered. 2021;12:9174–9188.
- Zhang M, Yang L, Hou L, et al. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer. Bioengineered. 2021;12:9239–9250.
- Sun M, Geng D, Li S, et al. LncRNA PART1 modulates toll-like receptor pathways to influence cell proliferation and apoptosis in prostate cancer cells. Biol Chem. 2018;399:387–395.
- Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102.
- You ZP, Zhang YL, Li BY, et al. Bioinformatics analysis of weighted genes in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2018;59:5558–5563.
- Jiang N, Meng X, Mi H, et al. Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancer. Clin Chim Acta. 2018;486:26–33.
- Su J, Zhang X, Zhao Q, et al. PD-1 mRNA expression in peripheral blood mononuclear cells as a biomarker for different stages of primary gouty arthritis. J Cell Mol Med. 2020;24(16):9323–9331.
- Sun X, Hu Y, Wu J, et al. RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer. J Exp Clin Cancer Res. 2018;37:298.
- Zhang Z, Huang A, Zhang A, et al. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA. Biomed Pharmacother. 2017;91:788–795.
- De Melo J, Tang D. Elevation of SIPL1 (SHARPIN) increases breast cancer risk. PLoS One. 2015;10:e0127546.
- Dambal S, Alfaqih M, Sanders S, et al. 27-hydroxycholesterol impairs plasma membrane lipid raft signaling as evidenced by inhibition of IL6-JAK-STAT3 signaling in prostate cancer cells. Mol Cancer Res. 2020;18:671–684.
- Jiang Y, Han S, Cheng W, et al. NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma. Cell Commun Signal. 2017;15(1):54.
- Ni JS, Zheng H, Ou YL, et al. miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway. Surg Oncol. 2020;34:113–120.
- Yao Y, Ye H, Qi Z, et al. B7-H4(B7x)-mediated cross-talk between glioma-initiating cells and macrophages via the IL6/JAK/STAT3 pathway lead to poor prognosis in glioma patients. Clin Cancer Res. 2016;22:2778–2790.